Terms: = Colorectal cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Clinical Outcome
3 results:
1. Tumor Budding and PDC Grade Are Stage Independent Predictors of clinical outcome in Mismatch Repair Deficient colorectal cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract] [Full Text] [Related]
2. Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: a meta-analysis.
Song QB; Wang Q; Hu WG
World J Gastroenterol; 2015 Apr; 21(14):4365-72. PubMed ID: 25892888
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptional profiles underpin microsatellite status and associated features in colon cancer.
Hogan J; DeJulius K; Liu X; Coffey JC; Kalady MF
Gene; 2015 Oct; 570(1):36-43. PubMed ID: 25704535
[TBL] [Abstract] [Full Text] [Related]
